Loeb, David M <br/><br/>
Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma.  [electronic resource] 

 -  Cancer  Dec 2010 
 - 5470-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.25518  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Bone Neoplasms--radiotherapy<br/>Female<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Male<br/>Organometallic Compounds--adverse effects<br/>Organophosphorus Compounds--adverse effects<br/>Osteosarcoma--radiotherapy<br/>Radiometry<br/>Radiopharmaceuticals--adverse effects<br/>Transplantation, Autologous